Clinical Trial Update: Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that Eyestem Research's Eyecyte-RPE is currently recruiting Phase 1/2 participants to evaluate safety and efficacy in geographi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Eyecyte-RPE

Snippet

Sponsor: Eyestem Research Pvt. Ltd. | Conditions: Retinal Disease, Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING